» Authors » David C Trampert

David C Trampert

Explore the profile of David C Trampert including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 111
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Trampert D
J Hepatol . 2024 Dec; 82(2):390-391. PMID: 39668012
No abstract available.
3.
Trampert D, Kersten R, Tolenaars D, Jongejan A, van de Graaf S, Beuers U
JHEP Rep . 2024 Mar; 6(4):101015. PMID: 38524667
Background & Aims: IgG4-related cholangitis (IRC) is the hepatobiliary manifestation of IgG4-related disease. Anti-laminin 511-E8 autoantibodies have been identified in its pancreatic manifestation. Laminin 511-E8 promotes endothelial barrier function, lymphocyte...
4.
Kersten R, Trampert D, Hubers L, Tolenaars D, Vos H, van de Graaf S, et al.
Front Immunol . 2024 Feb; 14:1251134. PMID: 38332916
Background And Aims: IgG4-related cholangitis (IRC) is the hepatobiliary manifestation of IgG4-related disease, a systemic B cell-driven fibro-inflammatory disorder. Four autoantigens have recently been described in IgG4-RD: annexin A11, galectin-3,...
5.
Trampert D, Kunst R, van de Graaf S
Curr Opin Gastroenterol . 2024 Jan; 40(2):62-69. PMID: 38230695
Purpose Of Review: Advances in the understanding of bile salt synthesis, transport and signalling show the potential of modulating bile salt homeostasis as a therapeutic strategy in cholestatic liver diseases....
6.
Trampert D, Beuers U
J Hepatol . 2024 Jan; 80(3):387-389. PMID: 38181824
No abstract available.
7.
Kersten R, Trampert D, Herta T, Hubers L, Maillette de Buy Wenniger L, Verheij J, et al.
J Hepatol . 2023 Aug; 79(6):1502-1523. PMID: 37598939
IgG4-related cholangitis (IRC) is the major hepatobiliary manifestation of IgG4-related disease (IgG4-RD), a systemic fibroinflammatory disorder. The pathogenesis of IgG4-RD and IRC is currently viewed as multifactorial, as there is...
8.
Beuers U, Trampert D
Ned Tijdschr Geneeskd . 2022 Oct; 166. PMID: 36300467
The physiologic bile acid ursodeoxycholic acid (UDCA) has potent anticholestatic and weak litholytic properties and has been used for centuries as a remedy for cholestatic liver diseases. Today, UDCA at...
9.
Trampert D, van de Graaf S, Jongejan A, Oude Elferink R, Beuers U
J Hepatol . 2021 May; 75(2):497. PMID: 33991636
No abstract available.
10.
Trampert D, van de Graaf S, Jongejan A, Oude Elferink R, Beuers U
J Hepatol . 2020 Dec; 74(2):428-441. PMID: 33342564
Many epithelia secrete bicarbonate-rich fluid to generate flow, alter viscosity, control pH and potentially protect luminal and intracellular structures from chemical stress. Bicarbonate is a key component of human bile...